Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...

Based on research and analysis of the global Pluripotent stem cell drug market, as well as studies and evaluations of relevant companies in the industry, Frost & Sullivan has granted ZEPHYRM ...

Researchers from Osaka University have revealed a close link between polyploidy and DNA damage, showing that the presence of ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then ...

Scientists from EMBL Hamburg and CSSB have uncovered the molecular mechanisms behind how the body absorbs vitamin B1, ...

Researchers are investigating whether drugs currently used for diabetes and eye diseases could help to prevent or treat ...

Polyploidy is a state where a cell contains more copies of the genetic material than the usual "diploid" cell, which contains two copies. Polyploidy often occurs in human diseases and cancers, and its ...